Dogs Gone Wild: Feral Dog Damage in the United States

Feral dogs have been documented in all 50 states and estimates of damage in the U.S. from these animals amount to >$620 million annually. In Texas alone, it is estimated that over $5 million in damage to livestock annually can be attributed to feral dogs. We reviewed national statistics on feral dog damage reported to USDA, APHIS, Wildlife Services for a 10-year period from 1997 through 2006. Damage by feral dogs crossed multiple resource categories (e.g., agriculture, natural resources); some examples of damage include killing and affecting the behavior and habitat use of native wildlife; killing and maiming livestock; and their role as disease vectors to wildlife, domestic animals, and humans. We review the role of dog damage in the U.S., synthesize the amount of damage between resource categories (agriculture, human health and safety, disease, and natural resources), and report trends in dog damage during the 10-year period. Results showed an increase in dog damage across all resource categories indicating the importance of management.

Who Suffers Most when Disease Outbreaks and Food Recalls Happen? The Case of Mad Cow Disease in the United States

It is generally observed that whenever there are cases of disease outbreaks and food recalls, such as the case of the 2003 Mad Cow Disease (Bovine Spongiform Encephalopathy or BSE) outbreak, cattle and beef prices fall. Given these incidents, there is the question of which part of the marketing chain is the most affected. For those who produce live cattle, such as feedlot operators, the question is ‘what effect these events have on price and demand for beef and cattle?’ Similarly, how do the Food Safety Inspection Service (FSIS) recalls and diseases such as Mad Cow Disease outbreaks affect the beef marketing margins at all levels in the U.S. beef marketing chain? Identifying these effects along the marketing chain provides insight into which level along that channel is the most vulnerable to these events. In addition, this information helps to assess the impact of such events on the industry, providing a basis for policy formulation.

STATUS OF BROMETHALIN OUTSIDE THE UNITED STATES

ABSTRACT: Bromethalin has been extensively researched over the past decade in the United States, Switzerland, England, Denmark, and France. United States EPA registrations were received in 1982 and commercial pelleted formulations containing 0.01% bromethalin were developed and introduced in the USA by Ralston Purina (ASSAULT1*) in 1985 and Velsicol (VENGEANCE1*) in 1986. Ciba-Geigy is currently developing new formulations under the tradename DORATIDR for use outside the United States. Bromethalin acute toxicity and 14-day subchronic studies are reviewed and data from recently completed 90-day subchronic studies required for registration outside the US are presented. Pharmacodynamic studies have shown that bromethalin acts as an uncoupler of oxidative phosphorylation, thus interrupting the vital production of ATP necessary to maintain essential metabolic functions. Laboratory and field trial data are presented from Switzerland, France, England, and Denmark that indicate the effectiveness of new bromethalin formulations against anticoagulant resistant and susceptible rodents. A comparative rodenticide pen testing system is described from which test results confirm bromethalin's quick action and feed consumption efficiency when compared to second-generation anticoagulants.